{"id":"W2128417569","doi":"10.1186/ar1854","title":"First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]","year":2006,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Celecoxib; Medicine; Osteoarthritis; Analgesic; Placebo; Rheumatology; Double blind; Randomized controlled trial; Anesthesia; Diclofenac; Pharmacology; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507207,0.001232543,0.004561344,0.0007421128,0.0004072655,0.001093005,0.001172043,0.002256322,0.007068275],"category_scores_gemma":[0.001581082,0.0008131423,0.00222724,0.0004481782,0.001179328,0.0009322251,0.0004068585,0.002578043,0.0008607075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005840559,"about_ca_system_score_gemma":0.0009199226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007668062,"about_ca_topic_score_gemma":0.0018858,"domain_scores_codex":[0.9993006,0.0003551931,0.00007121058,0.0001002819,0.00008116371,0.00009151854],"domain_scores_gemma":[0.9990847,0.0002753596,0.000252199,0.00004922225,0.00008090223,0.0002576018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768637,0.005773777,0.0002685815,0.0009843721,0.0008031246,0.00002495916,0.00002396337,0.000105765,0.003293901,0.00006408736,0.0003299351,0.01146377],"study_design_scores_gemma":[0.9161475,0.08072776,0.001414063,0.00003562122,0.0005365755,0.00002820497,0.00001366598,0.0002575873,0.0004850182,0.00004548256,0.0002976547,0.00001100932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701374,0.02030288,0.0006456836,0.000522732,0.001091878,0.003966528,0.0008195152,0.0001704631,0.002343112],"genre_scores_gemma":[0.9803572,0.008622734,0.001552492,0.0008204171,0.001146083,0.003465753,0.001147024,0.00002366368,0.002864524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007068275,"threshold_uncertainty_score":0.02364576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01561124858277347,"score_gpt":0.2983882175148674,"score_spread":0.282776968932094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}